Variant report
Variant | esv10115 |
---|---|
Chromosome Location | chr8:50330931-50348468 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567372730 | chr8:50332038-50332039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191242030 | chr8:50332057-50332058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17730041 | chr8:50332064-50332065 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs139074339 | chr8:50332070-50332071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78123296 | chr8:50332142-50332143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554232653 | chr8:50332165-50332166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572818506 | chr8:50332180-50332181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181268793 | chr8:50332218-50332219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538867162 | chr8:50332294-50332295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565245721 | chr8:50332295-50332296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185637328 | chr8:50332300-50332301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544447084 | chr8:50332326-50332327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562619109 | chr8:50332332-50332333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201292197 | chr8:50332333-50332334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552787765 | chr8:50332379-50332380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371600720 | chr8:50332380-50332381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374578760 | chr8:50332381-50332382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560260915 | chr8:50332417-50332418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75197439 | chr8:50332454-50332455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527692042 | chr8:50332462-50332463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs3206318 | chr8:50332481-50332482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546878647 | chr8:50332509-50332510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78981962 | chr8:50332517-50332518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571610474 | chr8:50332521-50332522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78325331 | chr8:50332523-50332524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76797439 | chr8:50332533-50332534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77598440 | chr8:50332556-50332557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375873889 | chr8:50332587-50332588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550823363 | chr8:50332607-50332608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568959041 | chr8:50332608-50332609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs386725129 | chr8:50332616-50332617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1674232 | chr8:50332655-50332656 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs554650637 | chr8:50332711-50332712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572710131 | chr8:50332740-50332741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569494795 | chr8:50332741-50332742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533823949 | chr8:50332776-50332777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558818829 | chr8:50332800-50332801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1621105 | chr8:50332803-50332804 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs140999871 | chr8:50332810-50332811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562711015 | chr8:50332821-50332822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575001090 | chr8:50332850-50332851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199497431 | chr8:50332851-50332852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541914125 | chr8:50332875-50332876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143520452 | chr8:50332882-50332883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200795313 | chr8:50332888-50332889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35477832 | chr8:50332889-50332890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554576681 | chr8:50332930-50332931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546266288 | chr8:50332931-50332932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190441275 | chr8:50332939-50332940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574569034 | chr8:50332943-50332944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50332000-50332200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr8:50332200-50338400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr8:50338400-50338600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:50339600-50340400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |